Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $6099.1.

  • Molecular Partners Ag's Total Non-Current Liabilities rose 572.72% to $6099.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $6099.1, marking a year-over-year increase of 572.72%. This contributed to the annual value of $6940.7 for FY2024, which is 9991.8% down from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's Total Non-Current Liabilities is $6099.1, which was up 572.72% from $5668.6 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Total Non-Current Liabilities high stood at $20.1 million for Q4 2021, and its period low was $4381.2 during Q1 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $9703.4 (2022), whereas its average is $4.0 million.
  • As far as peak fluctuations go, Molecular Partners Ag's Total Non-Current Liabilities tumbled by 9991.76% in 2024, and later surged by 572.72% in 2025.
  • Molecular Partners Ag's Total Non-Current Liabilities (Quarter) stood at $20.1 million in 2021, then plummeted by 49.12% to $10.2 million in 2022, then dropped by 17.15% to $8.5 million in 2023, then tumbled by 99.92% to $6970.1 in 2024, then fell by 12.5% to $6099.1 in 2025.
  • Its Total Non-Current Liabilities was $6099.1 in Q3 2025, compared to $5668.6 in Q2 2025 and $4381.2 in Q1 2025.